- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/17 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
Patent holdings for IPC class A61K 31/17
Total number of patents in this class: 1341
10-year publication summary
83
|
106
|
109
|
105
|
102
|
105
|
119
|
78
|
81
|
14
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2600 |
33 |
The Regents of the University of California | 18943 |
27 |
Bristol-myers Squibb Company | 5080 |
21 |
Hope Medical Enterprises, Inc. | 49 |
11 |
Lantern Pharma Inc. | 62 |
11 |
The Regents of the University of Michigan | 4409 |
10 |
Adamas Pharma, LLC | 49 |
10 |
Royalty Security, LLC | 24 |
10 |
Arete Therapeutics, Inc. | 23 |
9 |
Galderma Research & Development | 440 |
9 |
Neoculi Pty Ltd | 18 |
9 |
Remedy Pharmaceuticals, Inc. | 36 |
9 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
8 |
Duke University | 2872 |
8 |
Xeno Biosciences Inc., DBA Xeno Biosciences | 10 |
8 |
Société des Produits Nestlé S.A. | 9672 |
7 |
The Board of Trustees of the University of Illinois | 2623 |
7 |
Assistance Publique-hopitaux de Paris (aphp) | 427 |
7 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 829 |
7 |
Memorial Sloan-Kettering Cancer Center | 1789 |
7 |
Other owners | 1113 |